Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 14;22(1):85.
doi: 10.1186/s12941-023-00636-5.

Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study

Jane Wairimu Maina  1   2 , Frank Gekara Onyambu  3 , Peter Shikuku Kibet  4 , Abednego Moki Musyoki  5
Affiliations

Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study

Jane Wairimu Maina et al. Ann Clin Microbiol Antimicrob. .

Abstract

Background: Patients admitted to intensive care units (ICU) are at risk of Gram-negative bacteria (GNB) infections, especially those caused by multidrug-resistant (MDR) isolates, increasing morbidity, mortality, and healthcare costs. However, epidemiological surveillance data on MDR bacteria to inform infection prevention and control (IPCs) interventions is limited in our study setting. Here we assessed the prevalence and factors associated with GNB infections in ICU- patients admitted in our study setting.

Methods: This was a hospital-based cross-sectional study among patients admitted to ICU at the Nairobi West Hospital, Kenya, between January and October 2022. Altogether, we recruited 162 patients, excluding those hospitalized for less than 48 h and declining consent, and collected demographics and clinical data by case report form. Blood, wound and throat swab, ascetic tap, stool, urine, tracheal aspirate, and sputum samples were collected cultured. Isolates identity and antimicrobial susceptibility were elucidated using the BD Phoenix system.

Results: The prevalence of GNB infections was 55.6%, predominated by urinary tract infections (UTIs). We recovered 13 GNB types, with Escherichia coli (33.3%) and Klebsiella pneumoniae (31.1%) as the most common isolates. Factors associated with GNB infections were a history of antibiotic use (aOR = 4.23, p = 0.001), nasogastric tube use (NGT, aOR = 3.04, p = 0.013), respiratory tract (RT, aOR = 5.3, p = 0.005) and cardiovascular (CV, aOR = 5.7, p = 0.024) conditions. 92% of the isolates were MDR,predominantly Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.

Conclusion: We report a high prevalence of MDR-GNB infections, predominated by UTI, in ICU, whereby patients with a history of antibiotic use, using the NGT, and having RT and CV conditions were at increased risk. To improve the management of ICU-admitted patients, continuous education, training, monitoring, evaluation and feedback on infection prevention and control are warranted in our study setting.

Keywords: Gram-negative bacteria; Infections; Multidrug-resistance; Risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Figures

Fig. 1
Fig. 1
GNB spectrum and infections. GIT gastrointestinal tract infections, URTI upper respiratory tract infections, LRTI lower respiratory tract infections, BSI bloodstream infections, WI wound infections, UTI urinary tract infections, GNB Gram-negative bacteria
See this image and copyright information in PMC

References

    1. Saha M, Sarkar A. Review on multiple facets of drug resistance: a rising challenge in the 21st century. J Xenobiot. 2021;11(4):197–214. doi: 10.3390/jox11040013. - DOI - PMC - PubMed
    1. Abraham EP. The antibiotics. Compr Biochem. 1963;11(4):181–224. doi: 10.1016/B978-1-4831-9711-1.50022-3. - DOI
    1. Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules. 2020;25(6):1340. doi: 10.3390/molecules25061340. - DOI - PMC - PubMed
    1. Sengupta S, Barman P, Lo J. Opportunities to overcome implementation challenges of infection prevention and control in low-middle income countries. Curr Treat Options Infect Dis. 2019;11(3):267–280. doi: 10.1007/s40506-019-00200-w. - DOI
    1. Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR gram-negative bacteria. Front Med. 2019;6(April):1–10. - PMC - PubMed

Substances

LinkOut - more resources